Search for: "Black v. Pfizer, Inc."
Results 41 - 60
of 66
Sort by Relevance
|
Sort by Date
6 Jul 2010, 8:00 am
Black. [read post]
7 Apr 2010, 4:30 am
– Myriad stock prices: Association of Molecular Pathology v USPTO (Innovationpartners) US: Federal judge in Myriad patent case says invalidation of gene patents does not violate TRIPS: Association of Molecular Pathology v USPTO (KEI) US: ACLU gene patent decision from an investor’s perspective: A black eye for the US patent system: Association of Molecular Pathology v USPTO (Holman's Biotech IP Blog) US: Association of Molecular Pathology… [read post]
1 Mar 2010, 7:11 pm
Options Exchange Inc. v. [read post]
1 Mar 2010, 7:11 pm
Options Exchange Inc. v. [read post]
15 Dec 2009, 11:32 pm
In comparison, Pfizer Inc., parent of Wyeth, the maker of diet-drug combination fen-phen, has had to set aside about $21 billion to resolve about 200,000 personal-injury claims over that medicine. [read post]
2 Nov 2009, 7:11 am
The Court, with two Justices not participating, also asked the Solicitor General to express views on Pfizer Inc. v. [read post]
28 Sep 2009, 1:31 am
Black & Decker, (U.S.), Inc., 151 F.3d 765, 883-74 (8th Cir. 1998) (applying Missouri law); Anderson v. [read post]
28 Sep 2009, 1:31 am
Black & Decker, (U.S.), Inc., 151 F.3d 765, 883-74 (8th Cir. 1998) (applying Missouri law); Anderson v. [read post]
28 Sep 2009, 1:31 am
Black & Decker, (U.S.), Inc., 151 F.3d 765, 883-74 (8th Cir. 1998) (applying Missouri law); Anderson v. [read post]
24 Sep 2009, 5:09 am
Black & Decker, (U.S.), Inc., 151 F.3d 765, 883-74 (8th Cir. 1998) (applying Missouri law); Anderson v. [read post]
16 Aug 2009, 9:51 pm
In reliance of Black & Decker, Inc. v Robert Bosch Tool Corp (2008) Microsoft argued that the objective prong of the willfulness analysis is satisfied only if a defendant fails to present valid defences during the proceedings. [read post]
9 Mar 2009, 7:24 pm
Wyeth Company may be extremely sensitive to this decision as rival pharmaceutical company Pfizer Inc. is expected to buy out Wyeth for $68 billion later this year. [read post]
22 Jan 2009, 2:06 am
Pfizer Inc., 358 F.3d 659, 661 (9th Cir. 2004) (same; physician considered warning inappropriate) (applying California law).Under these facts, if Conte were an ordinary prescription drug product liability case, plaintiff would have been out of court and out of luck, just like Motus. [read post]
29 Dec 2008, 9:00 pm
Pfizer Inc., 867 N.Y.S.2d 425 (N.Y.A.D. 2008) (state appellate holding that plaintiff's home state controls on choice of law; similar to, but much better than, Desiano); (15) Vanderwerf v. [read post]
23 Oct 2008, 10:31 am
" According to the AP (10/22, Tanner), other "drugs under examination are Genentech Inc.'s psoriasis drug Raptiva (efalizumab), which just last week the Food and Drug Administration (FDA) warned may contribute to a life-threatening brain illness and infections; and Exubera, an inhaled insulin product, linked with lung cancer risks," which "Pfizer Inc. stopped selling...last year. [read post]
2 Oct 2008, 12:36 pm
Danek Medical, Inc., 1999 WL 1054864, *6 (M.D. [read post]
5 Sep 2008, 11:01 pm
& Ors v Deisel Spa and Case C-302/08 Zino Davidoff SA v Bendesfinanzdirektion Sudost: (Class 46), EPO Boards of Appeal finds that when a fax is transmitted and an ‘OK’ is noted by the sender, this is evidence that the transmission was successful: (IPKat), Professor Hugenholtz slams European Commission for ignoring evidence on copyright extension: (Techdirt) Germany Federal Patent Court publishes guidelines on colour trade mark Signal Yellow:… [read post]
27 Jun 2008, 10:04 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Court reconsidering baseless ‘making available’ theory in file-sharing case Capitol Records v Jammie Thomas; amicus briefs from, MPAA, PFF: (Electronic Frontier Foundation), (Electronic Fontier Foundation), (Techdirt), (Ars Technica), (Patry Copyright Blog), (Patry Copyright Blog) ICANN approves rules allowing brands to be… [read post]
29 Feb 2008, 8:00 am
– Teva’s opposition proceedings regarding IL 130424 to Pfizer: (IP Factor), Thailand: Thai chief drug price negotiator removed from post: (GenericsWeb), Thailand: Compulsory licences cannot be revoked: (Generic Pharmaceuticals & IP), (more from Generic Pharmaceuticals & IP), UK: Court of Appeal for England and Wales hands down decision in Boehringer Ingelheim KG and Boehringer Ingelheim Pharma KG v Swingward Limited relating to repackaging… [read post]
7 Feb 2008, 10:46 am
The leading case is Kemp v. [read post]
